You are here

Quest Diagnostics receives CEO Cancer Gold Standard™ accreditation

April 01, 2010
Cary, NC

Quest Diagnostics has received CEO Cancer Gold Standard™ accreditation, recognizing the organization’s commitment to taking concrete actions to reduce the cancer risk of its employees and their families through screenings, early detection, and healthy changes in lifestyle and in the workplace.

William C. Weldon, chairman and chief executive officer of Johnson & Johnson, chairs the CEO Roundtable on Cancer, a nonprofit organization of cancer-fighting CEOs who created the CEO Cancer Gold Standard™, in collaboration with the National Cancer Institute, many of its designated cancer centers, and leading health non-profit organizations and professionals. Today, nearly one and a quarter million employees and family members are benefiting from the vision and leadership of employers who have chosen to become Gold Standard accredited.
 
“We are pleased to recognize the efforts of Quest Diagnostics in the fight against cancer, starting with improving the health and wellness of their own employees,” said Weldon. “I hope the leadership and commitment demonstrated by Dr. Surya Mohapatra will encourage other CEOs  to take a more active role in the health of their employees by becoming Gold Standard accredited.”

The CEO Cancer Gold Standard™ calls for companies to evaluate their health benefits and corporate culture and take extensive, concrete actions in five key areas of health and wellness to fight cancer in the workplace. To earn Gold Standard accreditation, a company must establish programs to reduce cancer risk by discouraging tobacco use; encouraging physical activity; promoting healthy diet and nutrition; detecting cancer at its earliest stages; and providing access to quality care, including participation in clinical trials.

Employers are uniquely positioned to lead the fight against cancer and make a real difference in the health and wellbeing of their employees and their family members. The cost of cancer in the workplace is extraordinarily high considering the direct medical costs, lost productivity, disability claims and the tremendous personal toll the disease takes on individuals, families and coworkers.  CEO Cancer Gold Standard accreditation is awarded to organizations that demonstrate an exceptional, comprehensive commitment to fighting cancer by focusing on risk reduction, early detection and quality care.   While the focus of the Gold Standard is cancer, the benefits of encouraging healthy lifestyle choices extend to other serious and expensive chronic conditions and diseases such as obesity, diabetes, and cardiovascular disease.  The Gold Standard sends an important message to employees: “We are investing in your health because we care about you”.

About Quest Diagnostics
Quest Diagnostics is the world's leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at www.QuestDiagnostics.com.

Quest Diagnostics
Barb Short (Media):  P: 973-520-2800
Kathleen Valentine  (Investors):  P: 973-520-2900